Related Experiment Videos
Mutant presenilin (A260V) affects Rab8 in PC12D cell
Fuyuki Kametani1, Mihoko Usami, Kikuko Tanaka
1Department of Molecular Neurobiology, Tokyo Institute of Psychiatry, 2-1-8 Kamikitazawa, Setagayaku, Tokyo 156-8585, Japan. kametani@prit.go.jp
Neurochemistry International
|December 4, 2003
Summary
Familial early-onset Alzheimer's disease (FAD) mutations in presenilin-1 (PS1) disrupt cellular transport. This leads to the accumulation of amyloid precursor protein fragments (APP CTF) and reduced Abeta production.
Area of Science:
- Neuroscience
- Cell Biology
- Genetics
Background:
- Familial early-onset Alzheimer's disease (FAD) is primarily caused by mutations in the presenilin-1 (PS1) gene.
- Elevated levels of amyloid-beta 42 (Abeta) are a key indicator of abnormal PS1 function and are linked to Alzheimer's disease (AD).
- Understanding the interaction between PS1 and amyloid precursor protein (APP) is crucial for elucidating AD's molecular mechanisms.
Purpose of the Study:
- To investigate the impact of PS1 mutations on APP metabolism.
- To examine how PS1 mutations affect the transport of APP and its fragments within the cell.
Main Methods:
- Developed PC12D cell lines expressing either wild-type human PS1 or a mutant form (PS1A260V).
- Analyzed the levels of Rab8 GTPase, a protein involved in intracellular transport.
- Investigated the accumulation of APP C-terminal fragments (CTF) in cellular fractions.
Main Results:
- PC12D cells expressing the PS1A260V mutant showed significantly reduced levels of Rab8.
- APP CTF accumulated in heavy membrane fractions associated with trans-Golgi network (TGN) to plasma membrane (PM) transport.
- Total intracellular Abeta production was decreased in cells with the PS1A260V mutation.
Conclusions:
- PS1 mutations disrupt membrane vesicle transport, specifically along the TGN-to-PM pathway.
- The prolonged retention of APP CTF during transport is linked to reduced Abeta production.
- This study provides insights into the cellular mechanisms underlying FAD pathogenesis.